MedPath

LIDO BDK

Lidocaine and Prilocaine Cream USP, 2.5%/2.5%

Approved
Approval ID

51fd0589-e551-4583-98e1-1e8db19d7e6d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2018

Manufacturers
FDA

Asclemed USA, Inc.

DUNS: 059888437

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine, Prilocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76420-641
Product Classification
G
Generic Name
Lidocaine, Prilocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateNovember 1, 2018
FDA Product Classification

INGREDIENTS (6)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
CARBOMER 934Inactive
Code: Z135WT9208
Classification: IACT
POLYOXYL 60 HYDROGENATED CASTOR OILInactive
Code: 02NG325BQG
Classification: IACT
LIDOCAINEActive
Quantity: 25 mg in 1 g
Code: 98PI200987
Classification: ACTIB
PRILOCAINEActive
Quantity: 25 mg in 1 g
Code: 046O35D44R
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDO BDK - FDA Drug Approval Details